121 related articles for article (PubMed ID: 17132106)
1. Detailed analysis of MIA protein by mutagenesis.
Stoll R; Lodermeyer S; Bosserhoff AK
Biol Chem; 2006 Dec; 387(12):1601-6. PubMed ID: 17132106
[TBL] [Abstract][Full Text] [Related]
2. Cloning of a novel malignant melanoma-derived growth-regulatory protein, MIA.
Blesch A; Bosserhoff AK; Apfel R; Behl C; Hessdoerfer B; Schmitt A; Jachimczak P; Lottspeich F; Buettner R; Bogdahn U
Cancer Res; 1994 Nov; 54(21):5695-701. PubMed ID: 7923218
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of COOH-terminal binding protein expression in malignant melanomas leads to induction of MIA expression.
Poser I; Golob M; Weidner M; Buettner R; Bosserhoff AK
Cancer Res; 2002 Oct; 62(20):5962-6. PubMed ID: 12384563
[TBL] [Abstract][Full Text] [Related]
4. Functional role of MIA in melanocytes and early development of melanoma.
Poser I; Tatzel J; Kuphal S; Bosserhoff AK
Oncogene; 2004 Aug; 23(36):6115-24. PubMed ID: 15208686
[TBL] [Abstract][Full Text] [Related]
5. Cadherin-7 interacts with melanoma inhibitory activity protein and negatively modulates melanoma cell migration.
Winklmeier A; Contreras-Shannon V; Arndt S; Melle C; Bosserhoff AK
Cancer Sci; 2009 Feb; 100(2):261-8. PubMed ID: 19200257
[TBL] [Abstract][Full Text] [Related]
6. Expression levels of melanoma inhibitory activity correlate with time to progression in patients with high-grade glioma.
Hau P; Ruemmele P; Kunz-Schughart LA; Doerfelt A; Hirschmann B; Lohmeier A; Koch H; Mueller A; Bogdahn U; Bosserhoff AK
Oncol Rep; 2004 Dec; 12(6):1355-64. PubMed ID: 15547763
[TBL] [Abstract][Full Text] [Related]
7. Characterization and expression pattern of the novel MIA homolog TANGO.
Bosserhoff AK; Moser M; Buettner R
Gene Expr Patterns; 2004 Jul; 4(4):473-9. PubMed ID: 15183315
[TBL] [Abstract][Full Text] [Related]
8. Melanoma-inhibiting activity (MIA/CD-RAP) is expressed in a variety of malignant tumors of mainly neuroectodermal origin.
Hau P; Apfel R; Wiese P; Tschertner I; Blesch A; Bogdahn U
Anticancer Res; 2002; 22(2A):577-83. PubMed ID: 12014625
[TBL] [Abstract][Full Text] [Related]
9. Ultraviolet radiation induces release of MIA: a new mechanism for UVR-induced progression of melanoma.
Marr DG; Poser I; Shellman YG; Bosserhoff AK; Norris DA
Int J Oncol; 2004 Jul; 25(1):105-11. PubMed ID: 15201995
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of melanoma inhibitory activity (MIA) enhances extravasation and metastasis of A-mel 3 melanoma cells in vivo.
Guba M; Bosserhoff AK; Steinbauer M; Abels C; Anthuber M; Buettner R; Jauch KW
Br J Cancer; 2000 Nov; 83(9):1216-22. PubMed ID: 11027436
[TBL] [Abstract][Full Text] [Related]
11. Extracellular SH3 domain containing proteins--features of a new protein family.
Stoll R; Bosserhoff A
Curr Protein Pept Sci; 2008 Jun; 9(3):221-6. PubMed ID: 18537677
[TBL] [Abstract][Full Text] [Related]
12. Backbone dynamics of the human MIA protein studied by (15)N NMR relaxation: implications for extended interactions of SH3 domains.
Stoll R; Renner C; Buettner R; Voelter W; Bosserhoff AK; Holak TA
Protein Sci; 2003 Mar; 12(3):510-9. PubMed ID: 12592021
[TBL] [Abstract][Full Text] [Related]
13. Structure of melanoma inhibitory activity protein, a member of a recently identified family of secreted proteins.
Lougheed JC; Holton JM; Alber T; Bazan JF; Handel TM
Proc Natl Acad Sci U S A; 2001 May; 98(10):5515-20. PubMed ID: 11331761
[TBL] [Abstract][Full Text] [Related]
14. Elevated MIA serum levels are predictors of poor prognosis after surgical resection of metastatic malignant melanoma.
Guba M; Steinbauer M; Ruhland V; Schütz A; Geissler EK; Anthuber M; Vogt T; Bosserhoff A; Jauch KW
Oncol Rep; 2002; 9(5):981-4. PubMed ID: 12168059
[TBL] [Abstract][Full Text] [Related]
15. Active detachment involves inhibition of cell-matrix contacts of malignant melanoma cells by secretion of melanoma inhibitory activity.
Bosserhoff AK; Stoll R; Sleeman JP; Bataille F; Buettner R; Holak TA
Lab Invest; 2003 Nov; 83(11):1583-94. PubMed ID: 14615412
[TBL] [Abstract][Full Text] [Related]
16. Melanoma inhibitory activity promotes melanoma development through activation of YBX1.
Schmid R; Meyer K; Spang R; Schittek B; Bosserhoff AK
Pigment Cell Melanoma Res; 2013 Sep; 26(5):685-96. PubMed ID: 23672612
[TBL] [Abstract][Full Text] [Related]
17. The extracellular human melanoma inhibitory activity (MIA) protein adopts an SH3 domain-like fold.
Stoll R; Renner C; Zweckstetter M; Brüggert M; Ambrosius D; Palme S; Engh RA; Golob M; Breibach I; Buettner R; Voelter W; Holak TA; Bosserhoff AK
EMBO J; 2001 Feb; 20(3):340-9. PubMed ID: 11157741
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterization and chromosomal assignment of equine cartilage derived retinoic acid sensitive protein (CD-RAP)/melanoma inhibitory activity (MIA).
Berg LC; Mata X; Thomsen PD
Gene; 2008 Jan; 407(1-2):98-104. PubMed ID: 17977671
[TBL] [Abstract][Full Text] [Related]
19. Expression, function and clinical relevance of MIA (melanoma inhibitory activity).
Bosserhoff AK; Buettner R
Histol Histopathol; 2002 Jan; 17(1):289-300. PubMed ID: 11813878
[TBL] [Abstract][Full Text] [Related]
20. NMR-based Drug Development and Improvement Against Malignant Melanoma - Implications for the MIA Protein Family.
Arnolds O; Zhong X; Tuo Yip K; Schöpel M; Kohl B; Pütz S; Abdel-Jalil R; Stoll R
Curr Med Chem; 2017; 24(17):1788-1796. PubMed ID: 28595551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
